Navigation Links
Pharmacyclics Reports Third Quarter 2013 Results
Date:11/7/2013

se and milestone revenue

$
75,000$
,000$
25,000$
,000  Collaboration services revenue

4,0882,69511,6186,745Total revenue

79,088102,695136,618106,745Operating expenses*:  Research and Development

45,06619,072126,15050,285  Less: Excess amounts related to Research and Development

(34,146)-(51,523)-Research and Development, net

10,92019,07274,62750,285  General and Administrative

26,1204,86863,88213,149  Less: Excess amounts related to General and Administrative

(11,378)-(14,384)-General and Administrative, net

14,7424,86849,49813,149Total operating expenses

25,66223,940124,12563,434Income from operations

53,42678,75512,49343,311Interest and other income, net

14852204155Income before income taxes

53,57478,80712,69743,466Income tax provision (benefit)

11,2413,2019,924(2,411)Net income

$
42,333$
75,606$
2,773$
45,877Net income per share:Basic

$
.58$
.09$
.04$
.66Diluted

$
.55$
.02$
.04$
.62Weighted average shares used to computenet income per share:Basic

73,31669,51272,40969,149Diluted

77,65974,45676,68473,840* Includes share-based compensation as follows:Research and development

$
5,287$
2,590$
20,227$
,298General and administrative

4,84957620,3482,201$
,136$
3,166$
40,575$
8,499 

 Reconciliation of Selected GAAP Measures to Non-GAAP Measures (1)(unaudited; in thousands, except per share data)Three Months EndedNine Months EndedSep. 30,Sep. 30,Sep. 30,Sep. 30,2013201220132012GAAP net income$ 42,333$ 75,606$   2,773$ 45,877Adjustments:Research and Development share-based compensation (2)

5,2872,59020,2276,298General and Administrative share-based compensation (2)

4,84957620,3482,20110,1363,16640,5758,499Non-GAAP net income$ 52,469$ 78,772$ 4
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine technology :

1. Pharmacyclics Announces Date of Conference call to discuss Financial Results for Third Quarter Ended September 30, 2013
2. Pharmacyclics Reports Second Quarter 2013 Results
3. Pharmacyclics Announces Date of Financial Results for Second Quarter Ended June 30, 2013 and Conference Call
4. Pharmacyclics Reports First Quarter 2013 Results
5. Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
6. Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
7. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
8. Pharmacyclics, Inc. Prices Public Offering of Common Stock
9. Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
10. Pharmacyclics First to Announce Breakthrough Therapy Designation in Oncology from the U.S. Food and Drug Administration
11. Pharmacyclics Announces Date of Financial Results for Three and Six Months Ended December 31, 2012 and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... TORONTO , Aug. 27, 2015 /PRNewswire/ ... announced the issuance of a white paper on the ... spray product.  The white paper was presented to the ... by Dr. James H. Anderson, Jr. , MD, ... be viewed online on the Generex website. ...
(Date:8/27/2015)... Aug. 27, 2015  PinnacleHealth CardioVascular Institute enrolled the first ... the United States in a trial ... stent for blockages in the main artery of the leg. ... and potentially less risk for stent fracture or re-narrowing after ... single-arm, multicenter clinical trial of the BioMimics 3D Stent System ...
(Date:8/27/2015)... 27, 2015 According to ... Research titled "Global Market Study on Urinary Catheters: ... 2021", the urinary catheters market is expected to be valued ... It is anticipated to expand at a CAGR ... Mn by 2021. View full report TOC ...
Breaking Medicine Technology:Generex Announces Issuance of Buccal Insulin White Paper 2Generex Announces Issuance of Buccal Insulin White Paper 3Generex Announces Issuance of Buccal Insulin White Paper 4First Pennsylvania Patient Treated in Landmark Vascular Study 2Global Urinary Catheters Market Will Reach US$1,755.0 Mn by 2021: Persistence Market Research 2Global Urinary Catheters Market Will Reach US$1,755.0 Mn by 2021: Persistence Market Research 3Global Urinary Catheters Market Will Reach US$1,755.0 Mn by 2021: Persistence Market Research 4
... Mobile Dog Heart Health Tour is heading south to ... health examinations in San Antonio,s McAllister Dog Park. From ... veterinary cardiologists will be performing on site heart screenings ... owners about canine heart disease. (Photo: ...
... Celsis In Vitro, Inc. (Celsis IVT) announced today ... District of Illinois in Chicago has entered a preliminary ... (the Defendants) due to their infringement of U.S. Patent ... California (Nasdaq: LIFE ) is the parent ...
Cached Medicine Technology:Free Dog Heart Checks at McAllister Park 2Free Dog Heart Checks at McAllister Park 3Celsis IVT Wins Preliminary Injunction Against Life Technologies and CellzDirect in Liverpool™ Patent Infringement Lawsuit 2Celsis IVT Wins Preliminary Injunction Against Life Technologies and CellzDirect in Liverpool™ Patent Infringement Lawsuit 3
(Date:8/27/2015)... ... August 27, 2015 , ... For the first time, ... with the Nutri Ninja® Auto-iQ Pro Complete and Nutri Ninja Auto-iQ Compact System. ... takes drink customization to a whole new level. This line of Nutri Ninja ...
(Date:8/27/2015)... ... August 27, 2015 , ... Florida Hospital North Pinellas, located at 1395 South Pinellas Avenue ... of 2016. The new facility will be located at US Highway 19 North and Highlands ... on August 18, and work on the project is slated to begin in September 2015. ...
(Date:8/27/2015)... ... 27, 2015 , ... King Kullen, America’s First Supermarket, is celebrating 85 years ... in 1930 and recognized by the Smithsonian Institute as America’s First Supermarket, King Kullen ... the Cullen & Kennedy families have created a culture of caring while building their ...
(Date:8/27/2015)... ... August 27, 2015 , ... Since ... has grown to having twelve offices in three counties, LA, Orange and San ... Southern California region. Founded by Dr. Richy Agajanian, the Oncology Institute of ...
(Date:8/27/2015)... ... 27, 2015 , ... Catalent Pharma Solutions, the leading global ... health products, today announced that Ms. Esther Sadler-Williams, Global Director Strategic Development and ... Radisson Blu Edwardian Hotel, London Heathrow, on September 9th – 10th, 2015. , ...
Breaking Medicine News(10 mins):Health News:SharkNinja's Nutri Ninja® Auto-iQ™ Pro Complete Delivers Power And Versatility In A Compact Design 2Health News:SharkNinja's Nutri Ninja® Auto-iQ™ Pro Complete Delivers Power And Versatility In A Compact Design 3Health News:SharkNinja's Nutri Ninja® Auto-iQ™ Pro Complete Delivers Power And Versatility In A Compact Design 4Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 2Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 3Health News:King Kullen Honors Their 85 Years of Success this August 2Health News:California’s Largest Private Oncology Practice Serves 50,000 Patients in 8 years 2Health News:Clinical Trial Supply Chain Logistics to be Discussed By Catalent Expert at Upcoming Flypharma Conference 2
... ... Medical Chart Conversions to all ePaperless Solutions’ EMR System Clients on the East Coast ... ... -- Scantronix.net, an industry leader in electronic medical record (EMR) scanning, digitization and ...
... Jan. 15 Equinox Holdings, Inc. (the "Company") announced ... eligible purchasers, subject to market and other conditions, of ... 2016 (the "Notes").  The Notes will be guaranteed on a ... future subsidiaries that guarantee the Company,s new revolving credit facility, ...
... ... ( www.PharmaPack-US.com ), a Division of Label-Aire ( www.label-aire.com ) ... Mexico.,PharmaPack packaging machines are manufactured to cGMP specifications and our ... meet customers’ needs. Our product line consists of Unscramblers, ...
... ... of therapy products designed to relieve back pain and neck pain, is set to launch ... , ... 15, 2010 -- Tranquil Touch , LLC is proud to announce the launch of ...
... , ... have partnered to bring the CyberKnife Stereotactic Radiosurgery System to Miami , ... Chicago, IL (PRWEB) January 15, 2010 -- Accelitech ... in partnership with Mercy Hospital in Miami, Florida. , , ,With the launch of the ...
... Highly ... graduate , ... Nexis) January 15, 2010 -- The McGarity Group, a Gwinnett County law firm with special ... Braham has joined the firm as an associate attorney., , ,Braham began her professional ...
Cached Medicine News:Health News:Scantronix and ePaperlessSolutions Form Key Partnership 2Health News:Scantronix and ePaperlessSolutions Form Key Partnership 3Health News:Equinox Holdings, Inc. Commences $400 Million Private Debt Offering 2Health News:New Provider of Tablet/Capsule Packaging Solutions For Offers State-of-the-Art Equipment In The United States & Mexico 2Health News:Tranquil Touch, LLC to Introduce TheraPostion™ at the 2010 Parker Chiropractic Seminar in Las Vegas 2Health News:Tranquil Touch, LLC to Introduce TheraPostion™ at the 2010 Parker Chiropractic Seminar in Las Vegas 3Health News:Anne Marie Braham Joins The McGarity Group as Associate Attorney 2
Gentle curve facilitates less traumatic removal from eye. Increased length ideal for myopic eyes...
Great for small incisions and excision needs...
Cannula: .90mm x 28mm (20 G x 1 1/8 in) Handle: 9.3cm (3 5/8 in) long, Flute, .90 x 28mm, vacuum handle [Charles]...
2.5mm...
Medicine Products: